Zenith® Fenestrated+ Clinical Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 105 participants.

Also called NCT04875429

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 105 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04875429
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04875429. Allocation not applicable; no masking; primary purpose treatment. Start 2023-12-08 (actual); primary completion 2026-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Zenith® Fenestrated+ Clinical Study
Condition
Aortic Aneurysm, Abdominal
Condition
Juxtarenal Aortic Aneurysm
Condition
Extent IV Thoracoabdominal
Condition
Pararenal Aneurysm
Intervention (Device)
Zenith Fenestrated+ Endovascular Graft in combination with the BeGraft Balloon-Expandable FEVAR Bridging Stent Graft System and Unibody2
Lead sponsor
Cook Research Incorporated (class: industry)

Record details

Record id
cardio:ct-nct04875429
Content hash
0fb9a758fe2e4cfdb4ecb2527a47fc3f306125e6ecb0be279b766dfe61e27324